Clinical and Economic Impact of Upfront Next-Generation Sequencing for Metastatic NSCLC in East Asia
{{output}}
Introduction: Upfront next-generation sequencing (NGS) in patients with metastatic NSCLC has been associated with cost savings and shorter time-to-test results in the United States. Nevertheless, this may not apply in jurisdictio... ...
